Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections
Status:
NOT_YET_RECRUITING
Trial end date:
2025-03-15
Target enrollment:
Participant gender:
Summary
Treatment of dermatophyte infection in our country (Pakistan) is becoming difficult due to the developing resistance to traditional antifungal agents. Assessing the effectiveness ,feasibility and standard dosage of a newer antifungal drug like voriconazole is the need of the hour in resistant cases of dermatophyte infection.